Back to Search
Start Over
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
- Source :
- Clinical Infectious Diseases; 2/1/2023, Vol. 76 Issue 3, pe240-e249, 10p
- Publication Year :
- 2023
-
Abstract
- Background The rapid emergence of the Omicron variant and its large number of mutations led to its classification as a variant of concern (VOC) by the World Health Organization. Subsequently, Omicron evolved into distinct sublineages (eg, BA.1 and BA.2), which currently represent the majority of global infections. Initial studies of the neutralizing response toward BA.1 in convalescent and vaccinated individuals showed a substantial reduction. Methods We assessed antibody (immunoglobulin G [IgG]) binding, ACE2 (angiotensin-converting enzyme 2) binding inhibition, and IgG binding dynamics for the Omicron BA.1 and BA.2 variants compared to a panel of VOCs/variants of interest, in a large cohort (N = 352) of convalescent, vaccinated, and infected and subsequently vaccinated individuals. Results While Omicron was capable of efficiently binding to ACE2, antibodies elicited by infection or immunization showed reduced binding capacities and ACE2 binding inhibition compared to wild type. Whereas BA.1 exhibited less IgG binding compared to BA.2, BA.2 showed reduced inhibition of ACE2 binding. Among vaccinated samples, antibody binding to Omicron only improved after administration of a third dose. Conclusions Omicron BA.1 and BA.2 can still efficiently bind to ACE2, while vaccine/infection-derived antibodies can bind to Omicron. The extent of the mutations within both variants prevents a strong inhibitory binding response. As a result, both Omicron variants are able to evade control by preexisting antibodies. [ABSTRACT FROM AUTHOR]
- Subjects :
- BINDING sites
INTERFEROMETRY
STATISTICS
COVID-19
COVID-19 treatment
VIRAL proteins
COVID-19 vaccines
SERUM
LIQUID chromatography
MANN Whitney U Test
IMMUNOASSAY
MASS spectrometry
DESCRIPTIVE statistics
RESEARCH funding
VIRAL antibodies
SEROTHERAPY
VACCINATION status
DATA analysis software
STATISTICAL correlation
DATA analysis
ANGIOTENSIN converting enzyme
Subjects
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 76
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 161829705
- Full Text :
- https://doi.org/10.1093/cid/ciac498